Back to Dashboard$4.8B estimated savings over 10 years$1.2B CBO-scored savings over 10 years$6.3B CBO-scored savings over 10 years$8.6B combined annual revenue of listed drugs$450M for state implementation grants
PatientFirst Advocates
Patient AdvocacyDrug Pricing ReformHealth Equity
16 provisions tracked
10 positive
2 negative
1 conflict
PositiveSec. CMS-2026-0089 · CMS Medicare Drug Price Negotiation
Medicare Part D Negotiation Methodology Update
Expanded negotiation methodology aligns with PatientFirst mission — broader drug coverage means lower out-of-pocket costs for Medicare beneficiaries.
ACTION: Support public comment campaign praising expanded methodology. Coordinate grassroots mobilization for Senate Finance hearing.
PositiveSec. HR-4521 · Legislative — Biosimilar Competition
Biosimilar Competition Act
More biosimilar competition = lower drug prices for patients. PatientFirst strongly supports accelerated biosimilar access.
ACTION: Coordinate grassroots support campaign. Prepare patient testimony for Senate HELP Committee hearing.
PositiveSec. S-2847 · Legislative — Drug Pricing
Prescription Drug Affordability Act
Signature legislative priority for PatientFirst coalition. Affordability boards and price caps directly address member organizations' advocacy goals.
ACTION: Lead grassroots mobilization. Coordinate patient testimony for Finance Committee markup. Prepare state-level advocacy toolkit.
PositiveSec. CMS-2026-0178 · CMS IRA Drug Negotiation
IRA Drug Negotiation List Expansion (Round 3)
Expanded negotiation list is PatientFirst's top policy achievement. 20 additional drugs means lower costs for millions of Medicare beneficiaries.
ACTION: Coordinate public celebration and media strategy. Prepare advocacy materials for Round 4 expansion push.
PositiveSec. CMS-2026-0195 · CMS Medicaid Quality Reform
Medicaid Managed Care Quality Rating Update
Publicly reported quality ratings empower Medicaid beneficiaries to make informed plan choices. Aligns with PatientFirst transparency and accountability mission.
ACTION: Support public reporting provisions in comments. Coordinate with consumer advocacy partners on beneficiary education materials.